Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine May/22/2021 48 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Apr/28/2021 7 0
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Mar/20/2021 4 0
Daidzin Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021 2 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Feb/16/2021 4 0
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 4 0
Cynaroside Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 3 0
Oroxylin A Potential treatment - pre-clinical evidence Natural product Antiviral Feb/15/2021 1 0